King-Friend Biochemical Pharmaceutical Co. Ltd. Sustainability Profile
King-Friend Biochemical Pharmaceutical Co. Ltd., commonly referred to as King-Friend, is a prominent player in the pharmaceutical industry, headquartered in China (CN). Established in 1995, the company has made significant strides in the development and production of high-quality biochemical products, primarily focusing on APIs (Active Pharmaceutical Ingredients) and intermediates. With a strong operational presence across various regions, King-Friend has built a reputation for its innovative solutions in the pharmaceutical sector. The company’s core offerings include a diverse range of pharmaceutical raw materials, which are distinguished by their purity and compliance with international standards. Recognised for its commitment to quality and sustainability, King-Friend has achieved notable milestones, positioning itself as a trusted partner in the global pharmaceutical supply chain. Its dedication to research and development continues to drive its success in an increasingly competitive market.
DitchCarbon Score
How does King-Friend Biochemical Pharmaceutical Co. Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
King-Friend Biochemical Pharmaceutical Co. Ltd.'s score of 22 is lower than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
King-Friend Biochemical Pharmaceutical Co. Ltd.'s reported carbon emissions
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd., headquartered in China, currently does not report any specific carbon emissions data for the most recent year. However, the company is committed to climate action, as indicated by its near-term targets status, which is marked as "Committed." While no absolute emissions figures are available, King-Friend is actively engaged in initiatives to reduce its carbon footprint within the pharmaceuticals, biotechnology, and life sciences sector. The company has not set a net-zero target but is focused on implementing strategies to mitigate its environmental impact. As of December 2023, the company has not inherited emissions data from any parent or related organizations, indicating that its climate commitments are independently established. King-Friend's commitment to sustainability reflects a growing trend within the industry to address climate change proactively.
How Carbon Intensive is King-Friend Biochemical Pharmaceutical Co. Ltd.'s Industry?
How Carbon Intensive is King-Friend Biochemical Pharmaceutical Co. Ltd.'s Location?
King-Friend Biochemical Pharmaceutical Co. Ltd.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
King-Friend Biochemical Pharmaceutical Co. Ltd. has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
